Clinical Trial

Spotting and Managing Adult Repeated Traumas in the Brain

Study acronym: SMARTBRAIN
Recruiting
View on ClinicalTrials.gov →
Summary
Emerging evidence suggests that concussions (a type of mild traumatic brain injury; mTBIs) may cause chronic neurological disturbances with effects lasting beyond 20 years, changing brain structure and nearly doubling the risks of developing dementia into old age. Yet diagnoses remain notoriously difficult, gender differences are poorly understood, and negligible therapies exist to manage and treat these long-term effects. This project proposes using a combination of NeuroTracker (a promising software-based cognitive assessment and intervention for mild TBIs), with the latest MRI techniques and blood-based biomarkers of brain function, to provide unprecedented assessment sensitivity of long-term concussion effects, comparing older male and female adults, with and without a history of concussion. Additionally, NeuroTracker will be used as a therapeutic intervention to improve outcomes in adults with histories of concussion, with the combined assessments measuring efficacy pre-post training. This project aims to comprehensively understand the impacts of mild brain traumas into later life, via both physical and functional biomarkers of brain health. It will also validate the value of NeuroTracker as an accessible training intervention for recovering cognitive functions impacted by earlier-life concussions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-16.
Trial Details
NCT Number NCT07025317
Lead Sponsor Université de Montréal
Collaborators: University of Victoria, NeuroTracker Athletics Inc., Brain Canada, Consortium québécois sur la découverte du médicament
Conditions Brain Injury Traumatic Mild
Enrollment 200 participants
Start Date 2024-03-01
Primary Completion 2025-07-15 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-07-20